Ohio Public Employees Retirement System (OPERS)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,908
Closed -$1.35M 2048
2023
Q4
$1.35M Buy
22,908
+4,317
+23% +$243K 0.01% 1091
2023
Q3
$810K Sell
18,591
-2,059
-10% -$73.5K ﹤0.01% 1165
2023
Q2
$746K Sell
20,650
-1,537
-7% -$63.3K ﹤0.01% 1210
2023
Q1
$825K Sell
22,187
-688
-3% -$30.9K ﹤0.01% 1190
2022
Q4
$1.04M Buy
22,875
+1,281
+6% +$82.9K ﹤0.01% 1156
2022
Q3
$1.51M Buy
21,594
+170
+0.8% +$12.6K 0.01% 1121
2022
Q2
$1.44M Sell
21,424
-338
-2% -$21.5K 0.01% 1170
2022
Q1
$1.79M Sell
21,762
-801
-4% -$81.9K 0.01% 1132
2021
Q4
$3.31M Buy
22,563
+655
+3% +$102K 0.01% 932
2021
Q3
$3.88M Sell
21,908
-493
-2% -$79.3K 0.01% 881
2021
Q2
$3.62M Buy
+22,401
New +$3.6M 0.01% 917
2021
Q1
Sell
-567
Closed -$125K 2018
2020
Q4
$125K Buy
+567
New +$123K ﹤0.01% 1541

Other funds holding MRTX

Ohio Public Employees Retirement System (OPERS)'s MRTX Position: Q1 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 22,908 shares — an estimated $1.35M sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in MRTX in Q4 2020 and held it in 12 quarters. The position peaked at $3.88M in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 22,908 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.35M.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2020 and held it in 12 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Mirati Therapeutics, Inc. Common Stock position peaked at $3.88M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2024, filed 15 May 2024.